Ranexa is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium anatgonists).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
